This article is more than 5 years old. Information may no longer be current.

Health care division of Anteis renamed Aptissen

Issue: March 2014

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The health care division of Anteis has been established and renamed Aptissen, according to a press release.

Aptissen will now focus on ophthalmology and orthopedics. It is a leading supplier of ophthalmic viscosurgical devices, and products include Optheis, OptheisBio, Methylvisc and HealaFlow. Aptissen maintains the strong values of Anteis and will continue to develop top-quality next-generation products, the release said.

“Our major goal in 2014 is to develop our very good marketing standing on the national and international stage even further. We want to improve continuously and offer our customers the best products,” Oliver Benoit, CEO of Aptissen and former managing director of the health care division of Anteis, said in the release. — by Nhu Te